Skip to content
lifestyle.childcarepartnerships.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Lupin Pharmaceutical, Inc.
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
July 30, 2026
Lupin Announces the Approval of Diazepam Injection, USP in the United States
July 28, 2026
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
June 26, 2026
Lupin Launches Azilsartan Medoxomil Tablets in the United States
June 17, 2026
Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection
June 4, 2026